Weiden P L, Blaese R M, Strober W, Block J B, Waldmann T A
J Clin Invest. 1972 Jun;51(6):1319-25. doi: 10.1172/JCI106928.
Intestinal lymphangiectasia is a disease characterized by hypoproteinemia and edema resulting from protein-losing gastroenteropathy secondary to abnormal intestinal lymphatics. Immunologic abnormalities associated with this disease include hypogammaglobulinemia, lymphocytopenia, skin anergy, and impaired allograft rejection. In the present study, the in vitro blastogenic transformation of lymphocytes from 12 patients with intestinal lymphangiectasia was assessed in order to gain insight into the mechanism of the cellular immune defect in this disease. Peripheral blood lymphocytes from patients with intestinal lymphagiectasia showed impaired in vitro transformation to nonspecific mitogens, specific antigens, and allogeneic cells when compared to equal numbers of cells from normal individuals. Patients with the most deficient in vitro reactivity tended to have the lowest serum albumin concentration and the lowest absolute lymphocyte count. Lymphocytes obtained from chylous effusions in each of the four patients studied transformed more vigorously than peripheral blood cells from the same patients. These results may be explained by the loss of recirculating, long-lived lymphocytes into the gastrointestinal tract, resulting in a relative depletion of the population of lymphocytes necessary for in vitro blast transformation. This disease thus represents a clinical analogue of animals with experimental thoracic duct drainage, and provides evidence for the existence, in man, of two functionally distinct lymphocyte populations. In addition, these findings establish a new mechanism of impaired delayed hypersensitivity and defective in vitro lymphocyte transformation, i.e. the gastrointestinal loss and consequent depletion of the long-lived, recirculating population of lymphocytes from the peripheral lymphocyte pool.
肠淋巴管扩张症是一种由肠道淋巴管异常继发的蛋白丢失性胃肠病导致低蛋白血症和水肿的疾病。与该疾病相关的免疫异常包括低丙种球蛋白血症、淋巴细胞减少、皮肤无反应性以及同种异体移植排斥受损。在本研究中,评估了12例肠淋巴管扩张症患者淋巴细胞的体外增殖转化,以深入了解该疾病细胞免疫缺陷的机制。与正常个体等量的细胞相比,肠淋巴管扩张症患者的外周血淋巴细胞在体外对非特异性有丝分裂原、特异性抗原和同种异体细胞的转化受损。体外反应性最差的患者往往血清白蛋白浓度最低且绝对淋巴细胞计数最低。在所研究的4例患者中,从乳糜性积液中获得的淋巴细胞比同一患者的外周血细胞转化更活跃。这些结果可以解释为再循环的长寿淋巴细胞丢失到胃肠道中,导致体外增殖转化所需的淋巴细胞群体相对减少。因此,这种疾病代表了实验性胸导管引流动物的临床类似情况,并为人类存在两种功能不同的淋巴细胞群体提供了证据。此外,这些发现建立了迟发性超敏反应受损和体外淋巴细胞转化缺陷的新机制,即胃肠道丢失以及随之而来的外周淋巴细胞池中长寿的、再循环的淋巴细胞群体的耗竭。